James Healy, Director at Karuna Therapeutics, Inc. (KRTX), bought 9,114 shares at $73.75 ($672K) on 2020-09-09, disclosed to the SEC on 2020-09-11.
Open-market purchase of $672k KRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.75 | 4,557 | $336K | 50.0% |
| 2 | $73.75 | 4,557 | $336K | 50.0% |
| Total | $73.75 avg | 9,114 | $672K | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |